Measurement of circulating concentrations of cardiac troponin i and T in healthy subjects: A tool for monitoring myocardial tissue renewal?

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 10, 2009, Pages 1167-1177

  Giannoni, Alberto ^a   Giovannini, Stefania ^a   Clerico, Aldo ^a  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Cardiac markers; Cardiac troponin I; Cardiac troponin T; Healthy subjects

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; TROPONIN I; TROPONIN T;

AGING; BLOOD; CELL FUNCTION; CELLULAR DISTRIBUTION; CHEMICAL ANALYSIS; CIRCULATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; EXERCISE; HEART MUSCLE; HEART MUSCLE CELL; HEART OUTPUT; HUMAN; IMMUNOASSAY; LABORATORY TEST; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; SENSITIVITY ANALYSIS;

ANIMALS; AUTOANTIBODIES; EXERCISE; HEART; HUMANS; MYOCYTES, CARDIAC; TROPONIN I; TROPONIN T;

EID: 70349802010     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.320     Document Type: Review

References (108)

1. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969 (Pubitemid 30681627)
2. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/ WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-2195
3. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH, Cannon CP, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007;53:547-551
4. Zaninotto M, Mion M, Altinier S, Forni M, Plebani M. Quality specifications for biochemical markers of myocardial injury. Clin Chim Acta 2004;346:65-72.
5. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-332
6. Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009;402:88-93.
7. Panteghini M, Bunk DM, Christenson RH, Katrukha A, Porter RA, Schimmel H, et al. Standardization of troponin I measurements: an update. Clin Chem Lab Med 2008;46:1501-1506
8. Vittorini S, Clerico A. Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice. Clin Chem Lab Med 2008;46:748-763
9. Tate JR. Troponin revisited 2008: assay performance. Clin Chem Lab Med 2008;46:1489-1500
10. Prontera C, Fortunato A, Storti S, Mercuri A, Longombardo G, Zucchelli GC, et al. Evaluation of analytical performance of the Siemens ADVIA TnI ultra immunoassay. Clin Chem 2007;53:1722-1723
11. Venge P, James S, Jansson L, Lindahl B. Clinical performance of two highly sensitive cardiac troponin I assays. Clin Chem 2009;55:109-116
12. Clerico A, Fortunato A, Prontera C, Ripoli A, Zucchelli GC, Emdin M. Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations. Clin Chem Lab Med 2008;46:804-808
13. Prontera C, Fortunato A, Storti S, Mercuri A, Boni C, Zucchelli GC, et al. Evaluation of analytical performance of Advia TnI ultra immunoassay and comparison with Access AccuTnI method. Immuno-Analyse Biol Spec 2008;23:311-318
14. Sabatine MS, Morrow DA, de Lemos JA, Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009;30:162-169
15. Eggers KM, Lagerquist B, Venge P, Wallentin L, Lindahl B. Persistent troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation 2007;107:1907-1914
16. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-108
17. Hermsen D, Apple F, Garcia-Beltràn L, Jaffe A, Karon B, Lewandrowski E, et al. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay. Clin Lab 2007;53:1-9.
18. Jarausch J, Braun S, Dolci A, Jaffe A, Muhjbacher A, Oliver C, et al. Evaluation of a development version of the Elecsys high sensitive troponin T assay. Clin Chem 2008;54(Suppl 6):A91.
19. Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, Giannitsis E, et al. Multicentre evaluation of a high sensitive Elecsys troponin T assay. Clin Chem Lab Med 2009;47: S128.
20. Apple FS, Muratami MAM. Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd generation assays. Clin Chem 2007;53:1558-1560
21. Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007;128:282-286
22. Redpath M, Chalmers G, Dibden C, Morris B, Blumsohn A. Evaluation of imprecision of ADVIA Centaur- TNIUltra- automated immunoassay. Ann Clin Biochem 2008;45(Suppl 1):57.
23. Van de Kerkhof D, Peters B, Scharnhorst V. Performance of the Advia Centaur second-generation troponin assay TnI-Ultra compared with the first-generation cTnI assay. Ann Clin Biochem 2008;45:316-317
24. Collinson PO, Clifford-Mobley O, Gaze D, Boa F, Senior R. Assay imprecision and 99th-percentile reference value of a high-sensitivity cardiac troponin I assay. Clin Chem 2009;55:1433-1434
25. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007; 53:552-574 (Pubitemid 46580223)
26. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe ́ -Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324:98-102.
27. Swaanenburg JC, Visser-VanBrummen PJ, DeJongste MJ, Tiebosch AT. The content and distribution of troponin I, troponin T, myoglobin, and alpha-hydrobytyric acid dehydrogenase in the human heart. Am J Clin Pathol 2001;115:770-777
28. Solaro RJ, Rosevear P, Kobayashi T. The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. Biochem Biophys Res Commun 2008;369:82-87
29. Apple FS. Cardiac troponin testing in renal failure and skeletal muscle disease patients. In: Wu AH, editor. Cardiac markers, 2nd ed. Totowa (New Jersey 07512): Homan Press Inc, 2003:139-147
30. Apple FS, Murakami MM. The diagnostic utility of cardiac biomarkers in detecting myocardial infarction. Clin Cornerstone 2005;7(Suppl 1):S25-30.
31. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991;67:1360-1367
32. Bleier J, Vorderwinkler KP, Falkensammer J, Mair P, Dapunt O, Puschendorf B, et al. Different intracellular compartmentations of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damage. Clin Chem 1998; 44:1912-1918
33. Hessel MH, Atsma DE, van der Valk EJ, Bax WH, Schalij MJ, van der Laarse A. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch 2008;455:979-986
34. Hessel MH, Michielsen EC, Atsma DE, Schalij MJ, van der Valk EJ, Bax WH, et al. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. Exp Mol Pathol 2008;85:90-92
35. Wu AH, Jaffe AS, Apple FS, Jesse RL, Francis GL, Morrow DA, et al. NACB Writing Group, Cannon CP, Storrow AB. NACB Committee. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or Nterminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007;53:2086-2096
36. Agzew Y. Elevated serum cardiac troponin in non-acute coronary syndrome. Clin Cardiol 2009;32:15-20.
37. Jensen JK, Atar D, Mickley H. Mechanism of troponin elevations in patients with acute ischemic stroke. Am J Cardiol 2007;99:867-870 (Pubitemid 46365612)
38. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R. Intracellular action of matrix metalloproteinase- 2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 2002;106:1543-1549
39. Shyy JY, Chien S. Role of integrins in cellular responses to mechanical stress and adhesion. Curr Opin Cell Biol 1997;9:707-713
40. Clarke MS, Caldwell RW, Chiao H, Miyake K, McNeil PL. Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ Res 1995;76:927-934
41. Kaye D, Pimental D, Prasad S, Maki T, Berger HJ, McNeil PL, et al. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest 1996;97:281-291
42. McNeil PL, Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 1992;140:1097-1109
43. Page E, Upshaw-Earley J, Goings G. Permeability of rat atrial endocardium, epicardium, and myocardium to large molecules. Stretch-dependent effects. Circ Res 1992;71:159-173
44. Anversa P, Leri A, Kajstura J, Nadal-Ginard B. Myocyte growth and cardiac repair. J Mol Cell Cardiol 2002;34: 91-105.
45. Karsner HT, Saphir O, Todd TW. The state of the cardiac muscle in hypertrophy and atrophy. Am J Pathol 1925; 1:351-371
46. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998;83:1-14.
47. Buja LM, Vela D. Cariomyocyte death and renewal in the normal and diseased heart. Cardiovasc Pathol 2008; 17:349-374
48. Buja LM, Entman ML. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 1998;98:1355-1357
49. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing heart. N Engl J Med 1997;336:1131-1141
50. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998;83:1-14.
51. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998;95: 8801-8805
52. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344:1750-1757
53. Vats A, Bielby RC, Tolley NS, Nerem R, Polak JM. Stem cells. Lancet 2005;366:592-602.
54. Sell S. Adult stem cell plasticity. Stem Cell Rev 2005; 1:1-8.
55. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763-776
56. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003;100:12313-12318
57. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911-921
58. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005;85:1373-1416
59. Anversa P, Kajstura J, Leri A, Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 2006;113:1451-1463
60. Urbanek K, Cesselli D, Rota M, Nascimbene A, De Angelis A, Hosoda T, et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA 2006;103:9226-9231
61. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009;55:85-92.
62. Clerico A, Giannoni A, Prontera C, Giovannini S. Highsensitivity troponin assay: a new tool for pathophysiological investigation and its possible impact on clinical practice. Adv Clin Chem 2009;49:2-30.
63. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-1306
64. Illango RK. Utilizing NT-proBNP in the selection of risks for life insurance. J Insur Med 2007;39:182-191
65. Ribera-Casado JM. Ageing and the cardiovascular system. Z Gerontol Geritr 1999;32:412-419
66. Pugh KG, Wei JY. Clinical implications of physiological changes in the aging heart. Drugs Aging 2001;18:263-276
67. Eggers KM, Lind L, Ahlstrom H, Bjerner T, Ebeling Barbier C, Larsson A, et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 2008;29:2252-2258
68. Lippi G, Montagnana M, Guidi GC. The clinical dilemma of positive results of high-sensitive troponin assays. Am J Cardiol 2009;103:1332.
69. Kavsak PA, Macrae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009;55:573-577
70. Kazmierczak SC, Sekhon H, Richards C. False-positive troponin I measured with the Abbott AxSYM attributed to fibrin interference. Int J Cardiol 2005;101:27-31.
71. Zhu Y, Jenkins MM, Brass DA, Ravago PG, Horne BD, Dean SB, et al. Heterophilic antibody interference in an ultra-sensitive 3-site sandwich troponin I immunoassay. Clin Chim Acta 2008;395:181-182
72. Adamcyk M, Brashear RJ, Mattinly PG. Prevalence of autoantibodies to cardiac troponin T in healthy blood donors. Clin Chem 2009;55:1592-1593
73. Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory. Proposed guideline, 3rd ed. CLSI document C28-P3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
74. Hickman PE, Badrick T, Wilson SR, McGill D. Reporting of cardiac troponin - problems with the 99th population centile. Clin Chim Acta 2007;381:182-183
75. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA 3rd, et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007;115: 2358-2368
76. Neumayr G, Pfister R, Mitierbauer G, Maurer A, Gaenzer H, Sturm W, et al. Effect of the 'Race Across The Alps' in elite cyclists on plasma cardiac troponins 1 and T. Am J Cardiol 2002;89:484-486
77. Herrmann M, Scharhag J, Miclea M, Urhausen A, Herrmann W, Kindermann W. Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners. Clin Chem 2003;49:831-834
78. Roth HJ, Leithäuser RM, Doppelmayr H, Doppelmayr M, Finkernagel H, von Duvillard SP, et al. Cardiospecificity of the 3rd generation cardiac troponin T assay during and after a 216 km ultra-endurance marathon run in death valley. Clin Res Cardiol 2007;96:359-364
79. Fortescue EB, Shin AY, Greenes DS, Mannix RC, Agarwal S, Feldman BJ, et al. Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med 2007; 49:137-143
80. Middleton N, George K, Whyte G, Gaze D, Collinson P, Shave R. Cardiac troponin release is stimulated by endurance exercise in healthy humans. J Am Coll Cardiol 2008;52:1813-1814
81. Hubble KM, Fatovich DM, Grasko JM, Vasikaran SD. Cardiac troponin increases among marathon runners in the Perth Marathon: the Troponin in Marathons (TRIM) study. Med J Aust 2009;190:91-93
82. Mousavi N, Czarnecki A, Kumar K, Fallah-Rad N, Lytwyn M, Han SY, et al. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol 2009;103:1467-1472
83. Jassal DS, Moffat D, Krahn J, Ahmadie R, Fang T, Eschun G, et al. Cardiac injury markers in non-elite marathon runners. Int J Sports Med 2009;30:75-79
84. Whyte GP. Clinical significance of cardiac damage and changes in function after exercise. Med Sci Sports Exerc 2008;40:1416-1423
85. Lippi G, Schena F, Montagnana M, Salvagno GL, Guidi GC. Influence of acute physical exercise on emerging muscular biomarkers. Clin Chem Lab Med 2008;46: 1313-1318
86. Nie J, Tong TK, Shi Q, Lin H, Zhao J, Tian Y. Serum cardiac troponin response in adolescents playing basketball. Int J Sports Med 2008;29:449-452
87. Koller A, Sumann G, Griesmacher A, Falkensammer G, Klingler A, Fliri G, et al. Cardiac troponins after a downhill marathon. Int J Cardiol 2007. Published on line, Aug 7, 2009.
88. Shave R, George KP, Atkinson G, Hart E, Middleton N, Whyte G, et al. Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc 2007;39: 2099-2106
89. Michielsen EC, Wodzig WK, Van Dieijen-Visser MP. Cardiac troponin T release after prolonged strenuous exercise. Sports Med 2008;38:425-435
90. Chen Y, Serfass RC, Mackey-Bojack SM, Kelly KL, Titus JL, Apple FS. Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged intense exercise. J Appl Physiol 2000;88:1749-1755
91. Eriksson S, Hellman J, Pettersson K. Autoantibodies against cardiac troponins. N Engl J Med 2005;352:98-100.
92. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 2003;9:1477-1483
93. Lappé JM, Pelfrey CM, Tang WH. Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Cardiac Fail 2008;14:521-530
94. Yoshikawa T, Baba A, Nagatomo Y. Autoimmune mechanisms underlying dilated cardiomyopathy. Circ J 2009;73:602-607
95. Shmilovich H, Danon A, Binah O, Roth A, Chen G, Wexler D, et al. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Int J Cardiol 2007;117:198-203.
96. Leuschner F, Li J, Goser S, Reinhardt L, Ottl R, Bride P, et al. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 2008;29:1949-1955
97. Adamczyk M, Brashear RJ, Mattingly PG. Circulating cardiac troponin-I autoantibodies in human plasma and serum. Ann NY Acad Sci Forthcoming 2009.
98. Pettersson K, Eriksson S, Wittfooth S, Engdtrom E, Nieminen M, Sinisalo J. Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin in acute coronary syndrome patients. Clin Chem 2009;55:938-945
99. Kaya Z, Goser S, Buss SJ, Leuscher F, Ottl R, Li J, et al. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation 2008;118:2063-2072
100. Göser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 2006;114:1693-1702
101. Swaanenburg JC, Visser-VanBrummen PJ, DeJongste MJ, Tiebosch AT. The content and distribution of troponin I, troponin T, myoglobin, and alpha-hydrobytyric acid dehydrogenase in the human heart. Am J Clin Pathol 2001;115:770-777
102. Emdin M, Vittorini S, Passino C, Clerico A. Old and new biomarkers of heart failure. Eur J Heart Fail 2009;11: 331-335
103. Andreassi MG, Gastaldelli A, Clerico A, Salvadori PA, Sicari R, Picano E. Imaging and laboratory biomarkers in cardiovascular disease. Curr Pharm Des 2009;15: 1131-1141
104. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-1140 (Pubitemid 40839912)
105. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416. (Pubitemid 40283098)
106. Hunt SA, American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/ AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:e1-82.
107. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-2442
108. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update: ACCF/ AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016.